Abstract
Hemolysis due to donor-derived B lymphocytes has been reported in patients who have undergone ABO-nonidentical orthotopic liver transplantation (OLT). Yet, until now, little was known about the management of this transplantation-induced hemolysis. In this report we describe our experience with hemolysis in a patient after OLT. In addition, based on theoretical assumption, we hypothesize that corticosteroids can be helpful in the management of ABO-nonidentical OLT-induced hemolysis.
MeSH terms
-
ABO Blood-Group System / immunology*
-
Adoptive Transfer
-
Adrenal Cortex Hormones / therapeutic use*
-
Anemia, Hemolytic / drug therapy
-
Anemia, Hemolytic / etiology*
-
Antibodies, Anti-Idiotypic / immunology*
-
B-Lymphocytes / immunology
-
B-Lymphocytes / transplantation
-
Blood Group Incompatibility / drug therapy
-
Blood Group Incompatibility / etiology*
-
Blood Transfusion
-
Graft Rejection / etiology
-
Graft Rejection / prevention & control
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Liver / cytology
-
Liver / immunology
-
Liver Transplantation / adverse effects*
-
Liver Transplantation / immunology
-
Male
-
Middle Aged
-
Transplantation, Homologous / adverse effects
Substances
-
ABO Blood-Group System
-
Adrenal Cortex Hormones
-
Antibodies, Anti-Idiotypic
-
Immunosuppressive Agents